The 5 most recent market catalysts affecting $CCAP, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 10, 2026
Corporate Catalyst
Bearish
Impact 65
B of A Securities Downgrades Crescent Capital BDC to Neutral, Lowers Price Target to $10.25
B of A Securities analyst Derek Hewett downgraded Crescent Capital BDC (CCAP) from a 'Buy' to a 'Neutral' rating and significantly lowered its price target from $13 to $10.25. This…
Aug 17, 2026
Corporate Catalyst
Bearish
Impact 65
Keefe, Bruyette & Woods Downgrades Crescent Capital BDC to Market Perform, Lowers Price Target to $12
Keefe, Bruyette & Woods (KBW) downgraded Crescent Capital BDC (CCAP) from an 'Outperform' rating to 'Market Perform' and simultaneously lowered its price target from $13 to $12. Th…
Aug 12, 2026
Corporate Catalyst
Bearish
Impact 55
B. Riley Securities Maintains Neutral on Crescent Capital BDC, Lowers Price Target to $12.5
B. Riley Securities analyst Sean-Paul Adams has reduced the price target for Crescent Capital BDC (CCAP) from $13.5 to $12.5, while keeping a 'Neutral' rating. This action indicate…
Aug 10, 2026
Corporate Catalyst
Bearish
Impact 92
Crescent Capital BDC Q2 Adj. EPS $0.36 Misses $0.37 Estimate, Sales $36.323M Miss $37.316M Estimate
Crescent Capital BDC (CCAP) announced Q2 earnings where both adjusted EPS and sales fell short of analyst expectations. This matters because it signals underperformance relative to…
Jul 29, 2026
Corporate Catalyst
Neutral
Impact 75
FTC Grants Antitrust Clearance For Business Combination Between Churchill Capital And Agility Robotics
The filing indicates that the FTC has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for the business combination between Ch…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.